PT Hetzer Medical Indonesia Tbk (MEDS.JK)
IDR 50.0
(0.0%)
IDR 50.0
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 22.72 Billion IDR | -39.79% |
| 2022 | 37.73 Billion IDR | -50.21% |
| 2021 | 75.78 Billion IDR | -13.67% |
| 2020 | 87.78 Billion IDR | 630.26% |
| 2019 | 12.02 Billion IDR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 603.67 Million IDR | -87.52% |
| 2024 Q1 | 4.83 Billion IDR | -54.06% |
| 2023 Q4 | 10.52 Billion IDR | 113.45% |
| 2023 FY | 22.72 Billion IDR | -39.79% |
| 2023 Q3 | 4.93 Billion IDR | 41.32% |
| 2023 Q2 | 3.49 Billion IDR | -7.49% |
| 2023 Q1 | 3.77 Billion IDR | -38.47% |
| 2022 Q1 | 13.03 Billion IDR | 5.24% |
| 2022 FY | 37.73 Billion IDR | -50.21% |
| 2022 Q4 | 6.13 Billion IDR | 0.0% |
| 2022 Q2 | 9.74 Billion IDR | -25.22% |
| 2021 Q4 | 12.38 Billion IDR | 0.0% |
| 2021 Q1 | 25.55 Billion IDR | 0.0% |
| 2021 FY | 75.78 Billion IDR | -13.67% |
| 2020 FY | 87.78 Billion IDR | 630.26% |
| 2019 FY | 12.02 Billion IDR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| PT Mark Dynamics Indonesia Tbk | 559.46 Billion IDR | 95.938% |
| PT Jayamas Medica Industri Tbk | 1736.98 Billion IDR | 98.692% |
| Maja Agung Latexindo Tbk. | 81.71 Billion IDR | 72.193% |